IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Emcure Pharmaceuticals IPO listing price is ₹ 1358.85, issue price is [●], and currently trading at ₹ 1167.70 as on May 22, 2025. Emcure Pharmaceuticals IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Emcure Pharmaceuticals IPO is a Book Building listing on BSE,NSE exchange. The company is based in Pune and caters to Pharmaceutical sector. Axis Capital , J.P. Morgan India , Jefferies India , Kotak Mahindra Capital Company are the merchant bankers of Emcure Pharmaceuticals IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Emcure Pharmaceuticals IPO offer price is ₹ 1008.00 and got listed at ₹ 1358.85. Read Emcure Pharmaceuticals IPO details mentioned above.The IPO of Emcure Pharmaceuticals Limited was listed on 10th July 2024. As of today, Emcure Pharmaceuticals IPO is trading at ₹ 1167.70, compared to the previous day’s close of ₹ 1073.60. Read the report above for detailed IPO performance.
The issue price of Emcure Pharmaceuticals IPO was [●] per equity share.
Emcure Pharmaceuticals IPO was listed at ₹1358.85 on the stock exchange on 10th July 2024. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 22, 2025, the current market price of Emcure Pharmaceuticals IPO is ₹ 1167.70.
The 52-week high for Emcure Pharmaceuticals IPO is ₹ 1580.00, while the 52-week low is ₹ 889.00. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Emcure Pharmaceuticals IPO listed at ₹ 1358.85 against the issue price of [●] per equity share, showing a listing day gain/loss of 350.85 (34.81%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Emcure Pharmaceuticals IPO stock moved from its listing price of ₹ 1358.85 to the current price of ₹1167.70 per equity share, reflecting a change of -14.07% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Emcure Pharmaceuticals IPO issue date of May 22, 2025 and CMP of ₹1167.70, the estimated CAGR is approximately 18.33%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
[●]
Listing Price :
₹ 1358.85
Previous Day Closing
₹ 1073.60
Emcure Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Emcure Pharmaceuticals Financial Review Page
Merchant Banker(s) of Emcure Pharmaceuticals IPO: Axis Capital Limited , J.P. Morgan India Private Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited
Emcure Pharmaceuticals IPO subscription was 67.87 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Emcure Pharmaceuticals IPO listed at a listing price of 1358.85 against the offer price of 1008.00.
The current market price of Emcure Pharmaceuticals is 1167.70.
Why Us?
